www.immunogen.com
Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and headquarters in Cambridge, Massachusetts. (Nasdaq: IMGN)
URLs from www.immunogen.com:
URL: http://www.immunogen.com
Queries: